These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

250 related articles for article (PubMed ID: 23658122)

  • 1. Brief report: ultraviolet radiation exposure is associated with clinical and autoantibody phenotypes in juvenile myositis.
    Shah M; Targoff IN; Rice MM; Miller FW; Rider LG;
    Arthritis Rheum; 2013 Jul; 65(7):1934-41. PubMed ID: 23658122
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Ultraviolet radiation intensity predicts the relative distribution of dermatomyositis and anti-Mi-2 autoantibodies in women.
    Love LA; Weinberg CR; McConnaughey DR; Oddis CV; Medsger TA; Reveille JD; Arnett FC; Targoff IN; Miller FW
    Arthritis Rheum; 2009 Aug; 60(8):2499-504. PubMed ID: 19644877
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The myositis autoantibody phenotypes of the juvenile idiopathic inflammatory myopathies.
    Rider LG; Shah M; Mamyrova G; Huber AM; Rice MM; Targoff IN; Miller FW;
    Medicine (Baltimore); 2013 Jul; 92(4):223-243. PubMed ID: 23877355
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A novel autoantibody to a 155-kd protein is associated with dermatomyositis.
    Targoff IN; Mamyrova G; Trieu EP; Perurena O; Koneru B; O'Hanlon TP; Miller FW; Rider LG; ;
    Arthritis Rheum; 2006 Nov; 54(11):3682-9. PubMed ID: 17075819
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Predictors of clinical improvement in rituximab-treated refractory adult and juvenile dermatomyositis and adult polymyositis.
    Aggarwal R; Bandos A; Reed AM; Ascherman DP; Barohn RJ; Feldman BM; Miller FW; Rider LG; Harris-Love MO; Levesque MC; ; Oddis CV
    Arthritis Rheumatol; 2014 Mar; 66(3):740-9. PubMed ID: 24574235
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Association of Ultraviolet Radiation Exposure With Dermatomyositis in a National Myositis Patient Registry.
    Parks CG; Wilkerson J; Rose KM; Faiq A; Noroozi Farhadi P; Long CS; Bayat N; Brunner HI; Goldberg B; McGrath JA; Miller FW; Rider LG
    Arthritis Care Res (Hoboken); 2020 Nov; 72(11):1636-1644. PubMed ID: 31478597
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Seasonal influence on the onset of idiopathic inflammatory myopathies in serologically defined groups.
    Sarkar K; Weinberg CR; Oddis CV; Medsger TA; Plotz PH; Reveille JD; Arnett FC; Targoff IN; Genth E; Love LA; Miller FW
    Arthritis Rheum; 2005 Aug; 52(8):2433-8. PubMed ID: 16052581
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Clinical significance of specific autoantibodies in juvenile dermatomyositis.
    Feldman BM; Reichlin M; Laxer RM; Targoff IN; Stein LD; Silverman ED
    J Rheumatol; 1996 Oct; 23(10):1794-7. PubMed ID: 8895161
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Brief Report: Association of Myositis Autoantibodies, Clinical Features, and Environmental Exposures at Illness Onset With Disease Course in Juvenile Myositis.
    Habers GE; Huber AM; Mamyrova G; Targoff IN; O'Hanlon TP; Adams S; Pandey JP; Boonacker C; van Brussel M; Miller FW; van Royen-Kerkhof A; Rider LG;
    Arthritis Rheumatol; 2016 Mar; 68(3):761-8. PubMed ID: 26474155
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Myositis-specific autoantibodies and their association with malignancy in Italian patients with polymyositis and dermatomyositis.
    Ceribelli A; Isailovic N; De Santis M; Generali E; Fredi M; Cavazzana I; Franceschini F; Cantarini L; Satoh M; Selmi C
    Clin Rheumatol; 2017 Feb; 36(2):469-475. PubMed ID: 27761751
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Global surface ultraviolet radiation intensity may modulate the clinical and immunologic expression of autoimmune muscle disease.
    Okada S; Weatherhead E; Targoff IN; Wesley R; Miller FW;
    Arthritis Rheum; 2003 Aug; 48(8):2285-93. PubMed ID: 12905483
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Association of Short-Term Ultraviolet Radiation Exposure and Disease Severity in Juvenile Dermatomyositis: Results From the Childhood Arthritis and Rheumatology Research Alliance Legacy Registry.
    Neely J; Long CS; Sturrock H; Kim S;
    Arthritis Care Res (Hoboken); 2019 Dec; 71(12):1600-1605. PubMed ID: 30714338
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The juvenile idiopathic inflammatory myopathies: pathogenesis, clinical and autoantibody phenotypes, and outcomes.
    Rider LG; Nistala K
    J Intern Med; 2016 Jul; 280(1):24-38. PubMed ID: 27028907
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The clinical phenotypes of the juvenile idiopathic inflammatory myopathies.
    Shah M; Mamyrova G; Targoff IN; Huber AM; Malley JD; Rice MM; Miller FW; Rider LG;
    Medicine (Baltimore); 2013 Jan; 92(1):25-41. PubMed ID: 23263716
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Anti-NT5C1A autoantibodies are associated with more severe disease in patients with juvenile myositis.
    Yeker RM; Pinal-Fernandez I; Kishi T; Pak K; Targoff IN; Miller FW; Rider LG; Mammen AL;
    Ann Rheum Dis; 2018 May; 77(5):714-719. PubMed ID: 29363513
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Autoantibodies and their clinical significance in idiopathic inflammatory myopathies; polymyositis/dermatomyositis and related conditions.
    Hirakata M
    Nihon Rinsho Meneki Gakkai Kaishi; 2007 Dec; 30(6):444-54. PubMed ID: 18174673
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Clinical and serological characteristics of 125 Dutch myositis patients. Myositis specific autoantibodies aid in the differential diagnosis of the idiopathic inflammatory myopathies.
    Hengstman GJ; Brouwer R; Egberts WT; Seelig HP; Jongen PJ; van Venrooij WJ; van Engelen BG
    J Neurol; 2002 Jan; 249(1):69-75. PubMed ID: 11954871
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Autoantibodies to a 140-kd protein in juvenile dermatomyositis are associated with calcinosis.
    Gunawardena H; Wedderburn LR; Chinoy H; Betteridge ZE; North J; Ollier WE; Cooper RG; Oddis CV; Ramanan AV; Davidson JE; McHugh NJ;
    Arthritis Rheum; 2009 Jun; 60(6):1807-14. PubMed ID: 19479859
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Anti-FHL1 autoantibodies in juvenile myositis are associated with anti-Ro52 autoantibodies but not with severe disease features.
    Sherman MA; Graf R; Sabbagh SE; Galindo-Feria AS; Pinal-Fernandez I; Pak K; Kishi T; Flegel WA; Targoff IN; Miller FW; Lundberg IE; Rider LG; Mammen AL;
    Rheumatology (Oxford); 2023 Feb; 62(SI2):SI226-SI234. PubMed ID: 35961028
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Four dermatomyositis-specific autoantibodies-anti-TIF1γ, anti-NXP2, anti-SAE and anti-MDA5-in adult and juvenile patients with idiopathic inflammatory myopathies in a Hungarian cohort.
    Bodoki L; Nagy-Vincze M; Griger Z; Betteridge Z; Szöllősi L; Dankó K
    Autoimmun Rev; 2014 Dec; 13(12):1211-9. PubMed ID: 25182203
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.